ArticleFrontiers in oncology2020

Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases.

Xiaofang Ying et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.